Business

Lumos Secures 100% US Medicare Reimbursement for FebriDx

Lumos Secures 100% US Medicare Reimbursement for FebriDx

Lumos Diagnostics Holdings Ltd.November 21, 20255
Lumos Secures 100% US Medicare Reimbursement for FebriDx

About this update from Lumos Diagnostics Holdings Ltd.

Lumos Diagnostics Holdings Ltd has released a press release. View Attachment

View stock analysis, news, and events for Lumos Diagnostics Holdings Ltd.

More from Lumos Diagnostics Holdings Ltd.

All Lumos Diagnostics Holdings Ltd. news →